LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,207,287 | +97.4% | 308,690 | +107.4% | 0.00% | – |
| Q2 2023 | $611,732 | +98.6% | 148,840 | 0.0% | 0.00% | – |
| Q1 2023 | $308,098 | +65873.9% | 148,840 | 0.0% | 0.00% | – |
| Q4 2022 | $467 | -99.9% | 148,840 | +1.3% | 0.00% | – |
| Q3 2022 | $735,000 | +8.1% | 146,859 | +21.9% | 0.00% | – |
| Q2 2022 | $680,000 | +353.3% | 120,476 | +221.6% | 0.00% | – |
| Q1 2022 | $150,000 | -4.5% | 37,464 | +4.0% | 0.00% | – |
| Q4 2021 | $157,000 | -52.3% | 36,018 | 0.0% | 0.00% | – |
| Q3 2021 | $329,000 | +13.8% | 36,018 | -0.2% | 0.00% | – |
| Q2 2021 | $289,000 | -72.4% | 36,102 | -60.0% | 0.00% | – |
| Q1 2021 | $1,046,000 | +33.9% | 90,281 | +31.8% | 0.00% | – |
| Q4 2020 | $781,000 | +72.8% | 68,517 | +69.1% | 0.00% | – |
| Q3 2020 | $452,000 | +20.5% | 40,510 | +22.2% | 0.00% | – |
| Q2 2020 | $375,000 | – | 33,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
| Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
| Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
| Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
| Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
| RA Capital Management | 815,849 | $9,301,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
| Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |